The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States

Patricia Calderón Lloyd, Larissa S May, Daniel Hoffman, Richard Riegelman, Lone Simonsen

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42% of the patients were female and 73% were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS: Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.

Original languageEnglish (US)
JournalPediatric Infectious Disease Journal
Volume33
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Respiratory Syncytial Viruses
Hospitalization
Parturition
Respiratory Syncytial Virus Vaccines
International Classification of Diseases
Inpatients
Appointments and Schedules
Regression Analysis
Clinical Trials
Pediatrics
Pharmaceutical Preparations

Keywords

  • birth month
  • epidemiology
  • infants
  • Respiratory syncytial virus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)
  • Medicine(all)

Cite this

The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States. / Lloyd, Patricia Calderón; May, Larissa S; Hoffman, Daniel; Riegelman, Richard; Simonsen, Lone.

In: Pediatric Infectious Disease Journal, Vol. 33, No. 6, 2014.

Research output: Contribution to journalArticle

@article{7a6d085ba4d545759994a15370d03064,
title = "The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States",
abstract = "BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42{\%} of the patients were female and 73{\%} were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS: Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.",
keywords = "birth month, epidemiology, infants, Respiratory syncytial virus",
author = "Lloyd, {Patricia Calder{\'o}n} and May, {Larissa S} and Daniel Hoffman and Richard Riegelman and Lone Simonsen",
year = "2014",
doi = "10.1097/INF.0000000000000250",
language = "English (US)",
volume = "33",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States

AU - Lloyd, Patricia Calderón

AU - May, Larissa S

AU - Hoffman, Daniel

AU - Riegelman, Richard

AU - Simonsen, Lone

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42% of the patients were female and 73% were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS: Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.

AB - BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of severe respiratory illness in infants. To help direct targeted interventions and future RSV vaccine programs, we examined risk of RSV-related hospitalization by infant age and birth month. METHODS: We conducted Poisson regression analyses to evaluate birth month as a risk factor for RSV-related pediatric hospitalizations (identified by any mention of ICD-9-CM diagnosis codes: 466.11, 480.1 or 079.6) from State Inpatient Data in Arizona, Iowa, New York, Oregon and Wisconsin between July 1996 and June 2006. We used an age cohort approach to compute total relative risk of RSV during the first year of life. RESULTS: We identified 82,296 RSV-related infant hospital admissions, corresponding to 13.9 per 1000 person-years among infants <12 months of age. Of these, 42% of the patients were female and 73% were <6 months old. One-month-old infants born in January were ~10 times more at risk for RSV-related hospitalization than 1-month-old infants born in October [relative risk: 9.8 (7.8-12.4)]. Across the first year of life, infants born in December and January had a 2- and 3-fold higher risk, respectively, of an RSV-related hospitalization event than infants born in July. CONCLUSIONS: Birth month and age at admission impacted the risk of RSV-related hospitalization within the first year of life in 5 states we investigated. As RSV vaccine candidates are currently under investigation in clinical trials, our findings help identify ideal RSV vaccine schedules to prevent early and severe events while improving the use of expensive prophylactic drugs.

KW - birth month

KW - epidemiology

KW - infants

KW - Respiratory syncytial virus

UR - http://www.scopus.com/inward/record.url?scp=84901487717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901487717&partnerID=8YFLogxK

U2 - 10.1097/INF.0000000000000250

DO - 10.1097/INF.0000000000000250

M3 - Article

C2 - 24445838

AN - SCOPUS:84901487717

VL - 33

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 6

ER -